Exchange Commission,0.484756
EVP Norbert W.,0.219871
strong buy rating,0.5019
business’s stock,0.219871
investment analysts,0.460511
Company LLC,0.327009
consensus price target,0.478852
Robert W. Baird,0.272469
hold rating,0.460511
Equities research analysts,-0.307538
InvestorPlace Broker Center,0.555736
high fees,-0.735674
biopharmaceutical company,0.642682
personal trading style,0.598412
recent disclosure,0.484756
annualized basis,0.49869
research-based biopharmaceutical company,0.642682
firm,0.346726
target price,0.329717
ex-dividend date,-0.378179
Gilead Sciences Inc.,0.555178
research note,0.329717
average price,-0.277062
shares,-0.0571909
consensus estimate,0.424731
concise daily summary,0.447788
Gilead Sciences,0.155392
stock broker,0.245696
consensus rating,0.37068
chronic hepatitis,-0.646567
